GlycoVaxyn GlycoVaxyn AG
GlycoVaxyn GlycoVaxyn AG Glycovaxyn
GlycoVaxyn
Glycovaxyn Meeting Ag
GlycoVaxyn´s goal is to improve human health through the development of novel bioconjugate vaccines using its proprietary glycoprotein technology. GlycoVaxyn´s technology paves the way for synthesizing bioconjugate material to levels previously unattainable and in a more cost effective manner.
Glycovaxyn Meeting Ag
GlycoVaxyn´s goal is to improve human health through the development of novel bioconjugate vaccines using its proprietary glycoprotein technology. GlycoVaxyn´s technology paves the way for synthesizing bioconjugate material to levels previously unattainable and in a more cost effective manner.
Erfahrungen & Bewertungen Meeting
Beitrag oder Bewertung schreibenÖffnungszeiten
GlycoVaxyn GlycoVaxyn AG Öffnungszeiten:keine Angabe
€ Stand
Erfahrungen
StadtBranche.ch
GlycoVaxyn
glycovaxyn.ch
Wertung vom
2024-04-12:
https://stadtbranche.ch/erfahrung-glycovaxyn.ch.png
StadtBranche.ch Punkte
(Anzahl Besucher)
(Anzahl Besucher)
Adresse Ag Joint
Webseite | glycovaxyn.ch |
Name | GlycoVaxyn GlycoVaxyn AG |
Strasse | Grabenstrasse 3 « Karte |
Postleitzahl | 8952 |
Ort | Schlieren |
Umkreis | Schlieren |
Branche | Glycovaxyn in Schlieren |
Region | Zürich |
Telefon |
Glycovaxyn Meeting Ag Joint Glycobiology Technology Present Gent Glycovaxyn´s Home About Leadership Pipeline Partnerships News Publications Contact Dna Belgium Acs National Exposition San Francisco Usa Announces Inititation Phase I Clinical Trial Collaboration Janssen Society Honolulu The Baltic Microbial Carbohydrates Gdansk Copyright All Disclaimer Glossary
Beste Einträge zu Glycovaxyn sowie Meeting und Ag
1 GlycoVaxyn GlycoVaxyn AG GlycoVaxyn
glycovaxyn.ch GlycoVaxyn Human Health Development Novel Bioconjugate Vaccines Proprietary
8952
Schlieren
GlycoVaxyn´s goal is to improve human health through the development of novel bioconjugate vaccines using ... .
..
GlycoVaxyn AG to Present at the th Joint Glycobiology Meeting in GentBelgium
..Schlieren
glycovaxyn.ch GlycoVaxyn Human Health Development Novel Bioconjugate Vaccines Proprietary